Clinical trial ROSALINE
Neoadjuvant study of targeting ROS1 in combination with endocrine therapy in invAsive Lobular carcINoma of the breast
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | Institut Jules Bordet |
EudraCT Identifier | 2019-004942-14 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04551495 |
Last update |